BNTC

Benitec Biopharma Inc.

Price

$8.50

return (12m)

-48.04%

p/e

-10.24

p/bv

2.32

DIVIDEND YIELD

0.00%

BNTC price

Benitec Biopharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment BNTC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-6.08%

3 months

-31.17%

1 year

-48.04%

2 years

-22.16%

5 years

-86.45%

10 years

-97.81%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BNTC

Valuation

P/E

-10.24

Sector -3.16

Industry -3.16

P/BV

2.32

Sector 1.80

Industry 1.80

P/Revenue (PSR)

Sector 2.04

Industry 2.04

EV/EBITDA

-5.22

Sector -204.34

Industry -204.34

EV/EBIT

-5.17

Sector -42.58

Industry -42.58

P/EBITDA

-9.23

Sector -19.73

Industry -19.73

P/EBIT

-9.13

Sector -67.09

Industry -67.09

P/Total Assets

2.28

Sector 1.06

Industry 1.06

P/Net Current Assets

2.33

Sector -9.56

Industry -9.56

P/Working Capital

2.33

Sector -93.82

Industry -93.82

EPS

-0.85

Sector -1.78

Industry -1.78

BVPS

3.74

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

0.00%

Sector 41.28%

Industry 41.28%

EBITDA Margin

Sector -21,198.78%

Industry -21,198.78%

EBIT Margin

0.00%

Sector -35.28%

Industry -35.28%

Net Profit Margins

0.00%

Sector -35.71%

Industry -35.71%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-29.58%

Sector -61.32%

Industry -61.32%

ROA

-28.43%

Sector -54.29%

Industry -54.29%

ROIC

-2,687.51%

Sector -1,801.33%

Industry -1,801.33%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

56.89

Sector 2.91

Industry 2.91

Net Debt / EBITDA

4.01

Sector -20.38

Industry -20.38

Net Debt / EBIT

3.97

Sector -4.13

Industry -4.13

Net Debt / Equity

-1.01

Sector -33,112.98

Industry -33,112.98

Gross Debt / Equity

0.00

Sector -0.64

Industry -0.64

Equity/Assets

0.98

Sector 0.46

Industry 0.46

Liabilities/Assets

0.02

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

18.51%

Sector -

Industry -

Fundamentals BNTC

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BNTC Benitec Biopharma Inc.	$8.50	-48.04%	0.00%	-10.24	2.32	-29.58%	0.00%
PFE Pfizer Inc.	$30.41	33.97%	5.73%	39.46	2.00	4.97%	6.80%
ABBV AbbVie Inc.	$288.29	36.44%	2.31%	53.66	0.00	-%	14.76%
NVO Novo Nordisk A/S	$40.49	-13.45%	4.66%	9.73	5.17	60.28%	35.32%
MRK Merck & Co. Inc.	$145.20	73.83%	2.27%	116.34	8.79	6.97%	4.77%
AZN AstraZeneca PLC	$185.11	15.21%	1.73%	22.38	5.77	27.27%	16.95%
BMY Bristol-Myers Squibb Company	$62.63	41.99%	5.06%	13.78	5.44	44.06%	18.47%
ZTS Zoetis Inc.	$83.43	-40.99%	2.60%	12.71	10.64	64.91%	27.69%
AMGN Amgen Inc.	$464.48	60.80%	2.13%	28.86	21.58	91.47%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$973.63	52.20%	0.41%	21.68	2.96	14.04%	27.86%
HALO Halozyme Therapeutics Inc.	$130.37	99.98%	0.00%	37.10	106.90	173.67%	24.86%
MCK McKesson Corporation	$1,008.67	24.93%	0.34%	25.96	-30.85	-168.45%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$536.30	26.02%	0.00%	32.22	7.01	23.54%	35.00%
CAH Cardinal Health Inc.	$255.97	35.45%	0.81%	34.74	-21.86	-63.98%	0.67%
ARGX argenx SE	$883.95	8.00%	0.00%	13.26	-	-%	25.42%
HRMY Harmony Biosciences Holdings Inc.	$38.00	33.01%	0.00%	12.39	2.25	20.46%	18.88%
BIIB Biogen Inc.	$251.87	63.27%	0.00%	45.08	2.00	4.58%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BNTC - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	05/31/2018	06/08/2018	0.73950000

ABOUT Benitec Biopharma

Benitec Biopharma Inc.

Average Investor10 user rating

4.0 (1 people)

United States

7 years

Founded: 2019

2012

Time since IPO - 14 years

14

Employees

Benitec Biopharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $425.57 million, with shareholders equity totaling $183.33 million.

The company employs approximately 14 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Benitec Biopharma Inc. reported $- in revenue, generating net income of $-41.54 million.

Key financial metrics include a P/E ratio of -10.24, a price-to-book (P/B) ratio of 2.32, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BNTC.

Market cap

$425.57 million

Net worth

$183.33 million

$183,330,000.00

Assets

$187.00 million

$187,000,000.00

Total Shares Outstanding

49.00 million

49,000,000

Average Daily Trading Volume

$167.43 Thousand

$167,426.00

Sector

Health Care

Industry

Biotechnology

BNTC

BNTC revenue and profits

Financial Results BNTC

DRAG THE FRAME TO SEE MORE DATA

BNTC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$1,008.67 23,56% (12M)

P/E

25.96

0.34%

ROE

-168.45%

P/BV

-30.85

CAH - Cardinal Health

$255.97 35,84% (12M)

P/E

34.74

0.81%

ROE

-63.98%

P/BV

-21.86

ABBV - AbbVie

$288.29 40,35% (12M)

P/E

53.66

2.31%

ROE

P/BV

0.00

MRK - Merck & Co.

$145.20 81,18% (12M)

P/E

116.34

2.27%

ROE

6.97%

P/BV

8.79

AZN - AstraZeneca

$185.11 14,78% (12M)

P/E

22.38

1.73%

ROE

27.27%

P/BV

5.77

PFE - Pfizer

$30.41 33,92% (12M)

P/E

39.46

5.73%

ROE

4.97%

P/BV

2.00

BMY - Bristol-Myers Squibb

$62.63 42,14% (12M)

P/E

13.78

5.06%

ROE

44.06%

P/BV

5.44

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$1,008.67 23,56% (12 M)

P/L

25.96

0.34%

ROE

-168.45%

P/VP

-30.85

CAH - Cardinal Health

$255.97 35,84% (12 M)

P/L

34.74

0.81%

ROE

-63.98%

P/VP

-21.86

ABBV - AbbVie

$288.29 40,35% (12 M)

P/L

53.66

2.31%

ROE

P/VP

0.00

MRK - Merck & Co.

$145.20 81,18% (12 M)

P/L

116.34

2.27%

ROE

6.97%

P/VP

8.79

AZN - AstraZeneca

$185.11 14,78% (12 M)

P/L

22.38

1.73%

ROE

27.27%

P/VP

5.77

PFE - Pfizer

$30.41 33,92% (12 M)

P/L

39.46

5.73%

ROE

4.97%

P/VP

2.00

BMY - Bristol-Myers Squibb

$62.63 42,14% (12 M)

P/L

13.78

5.06%

ROE

44.06%

P/VP

5.44

Frequently Asked Questions

What is the price of Benitec Biopharma (BNTC) today?

The current price of Benitec Biopharma (BNTC) is $8.50. The stock began the year trading around $13.47 and is currently priced at $8.50. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Benitec Biopharma (BNTC) pay dividends?

Benitec Biopharma (BNTC) did not pay dividends over the past year.

Is Benitec Biopharma (BNTC) a good investment?

Benitec Biopharma (BNTC) is currently trading at $8.50 with a P/E ratio of -10.24. This represents a -902% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -48.04%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Benitec Biopharma (BNTC) stock?

You can buy Benitec Biopharma (BNTC) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol BNTC and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Benitec Biopharma (BNTC) yield today?

Over the past month, Benitec Biopharma (BNTC) has returned -6.08% — -48.04% over the past year, and -86.45% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Benitec Biopharma (BNTC) today at the current price of $8.50 your total investment would be $850.00.

Based on historical performance, the investment would have grown to approximately:

$441.66 after 1 year
$115.18 after 5 years
$18.62 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BNTC

Benitec Biopharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BNTC

Target price created!

Delete target price?

Your Target Price strategy deserves unlimited alerts

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING BNTC WITH OTHER STOCKS

type

Ex - Dividend Date

payment date

value

ABOUT Benitec Biopharma

Benitec Biopharma Inc.

United States

7 years

2012

14

PROFIT X PRICE BNTC

Financial Results BNTC

BNTC cash flow

Asset, Revenue and Profit Growth - BNTC

BNTC balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions